iBio (AMEX:IBIO) 報告其季度每股虧損 $(0.48)，未能達到分析師共識預期的 $(0.32)，差距爲 50%。這相比去年同期每股虧損 $(2.42) 增長了 80.17%。該公司本季度報告銷售額爲 $200.00千美元。

以上內容來自Benzinga Earnings專欄，原文如下：

iBio (AMEX:IBIO) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.32) by 50 percent. This is a 80.17 percent increase over losses of $(2.42) per share from the same period last year. The company reported $200.00 thousand in sales this quarter.